<DOC>
	<DOCNO>NCT02021006</DOCNO>
	<brief_summary>The exact role urinary tract infection appearance chronic kidney disease unclear . Children congenital malformation kidney urinary tract high risk impairment renal function . To understand use antibiotic prophylaxis reduce risk urinary tract infection child malformation , study randomize child two group . Group A take antibiotic prophylaxis , Group B take antibiotic prophylaxis 2 year . This study assess antibiotic prophylaxis reduce risk urinary tract infection child urinary tract infection influence appearance renal damage . Our hypothesis prophylaxis reduce risk infection severe vesicoureteral reflux urinary tract infection , morphologically normal kidney , result chronic renal failure .</brief_summary>
	<brief_title>Antibiotic Prophylaxis Renal Damage In Congenital Abnormalities Kidney Urinary Tract</brief_title>
	<detailed_description>Bacterial urinary tract infection ( UTI ) common young child . The presence fever consider marker renal parenchymal involvement . Renal damage acute phase infection may lead scarring , yet role scar play appearance chronic kidney failure unknown . It also unclear influence scar natural course kidney function , especially child renal hypodysplasia , without vesicoureteral reflux ( VUR ) . Renal hypodysplasia common cause dialysis transplantation pediatric population . Patients suffer recurrent UTIs VUR often undergone corrective surgery . For many year , also think necessary prescribe long-term antibiotic prophylaxis child VUR . These treatment strategy base idea opinion expert , rather hard scientific evidence . As regard prevention recurrent UTIs subsequent development renal scarring , long-term international study Reflux able demonstrate surgical correction effective antibiotic prophylaxis . Very little data available regard use long-term antibiotic prophylaxis child high grade reflux without renal hypodysplasia . The use antibiotic first month life associate significant increase body mass index ( BMI ) . Even though effect probably limit , could significant impact public health give widespread use antibiotic due considerable increase case pediatric adult obesity see last year . In spite lack evidence , use prophylaxis largely routine practice centre . Therefore , randomize study necessary order evaluate whether prophylaxis reduces risk symptomatic infection subsequent renal damage . To assess role prophylaxis patient high grade vesicoureteral reflux perform multicentre , prospective , randomize , control , open-label , study . Patients enrol randomized two group : Group A : antibiotic prophylaxis . Group B : antibiotic prophylaxis 24 month . The choice antibiotic prescribe list leave discretion investigator , basis local antibiotic resistance pattern . - nitrofurantoin 1.5-2 mg/kg per day - amoxicilline/clavulanic acid 15 mg/kg per day ( dose express unit equivalent amoxicillin ) - cefixime 2 mg/kg per day - trimethoprim/sulfamethoxazole 2.5 mg/kg per day ( dose express unit equivalent trimethoprim ) The study comprise : - Phase 1 : Pre-randomization - screening test determine eligibility trial . - Phase 2 : Active treatment - phase follow randomization foresees 24 month antibiotic prophylaxis Group B clinical surveillance Group A . - Phase 3 : Follow-up - 36 month clinical , laboratory instrumental evaluation renal function progression renal damage total follow-up period 5 year</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Vesico-Ureteral Reflux</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Cefixime</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Nitrofurantoin</mesh_term>
	<criteria>Age 1 4 month Gestational age &gt; 35 week Glomerular filtration rate ( calculate accord Schwartz ) &gt; 15 ml/min/1.73 m2 No previous symptomatic UTI Imaging Diagnostic workup complete presence grade III V vesicoureteral reflux Informed consent parent Age &lt; 1 &gt; 4 month Gestational age &lt; 35 week Glomerular filtration rate ( calculate accord Schwartz ) &lt; 15 ml/min/1.73 m2 three month age Patients neurogenic bladder , myelomeningocele , ureteropelvic junction and/or ureterovesical junction obstruction , malformation lead potential voiding disturbance , apart urethral valve Patients low grade reflux ( grade I II ) . Hypersensitivity utilized antimicrobial agent Children serious clinical condition , accord investigator , prevent include study cohort . Use experimental drug month previous begin study Children unable follow establish protocol procedure whose parent unable sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>antibiotic prophylaxis</keyword>
	<keyword>vesicoureteral reflux</keyword>
	<keyword>congenital abnormality kidney</keyword>
	<keyword>renal hypodysplasia</keyword>
	<keyword>chronic kidney disease</keyword>
</DOC>